John Xue is an accomplished investment professional currently serving as Investment Vice President at SoftBank Investment Advisers, focusing on healthcare and technology investments since 2021. In addition, John holds several board director positions at Umoja Biopharma, Variant Bio, and Karius, and serves as a board observer at Dewpoint Therapeutics. Prior experience includes working as an Engagement Manager at McKinsey & Company, where John specialized in healthcare, R&D, and advanced analytics, supporting a variety of clients. Earlier roles also include Associate at Lazard and Summer Analyst in mergers and acquisitions. John earned a PhD in Cell/Cellular and Molecular Biology from The Rockefeller University and a BA in Biochemistry from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices